麦角酸二乙酰胺（LSD）与精神分裂症的发病

Can J Psychiatry. 1981 Feb;26(1):64-5. doi: 10.1177/070674378102600113.

In a matched controlled study 37 chronic schizophrenics who had taken LSD preceding the onset of their illness were compared with schizophrenics who had not. There were no significant differences between the groups either on age at onset of symptoms or for age at first admission.

在一项配对对照研究中，将37名在疾病发作前服用过麦角酸二乙酰胺（LSD）的慢性精神分裂症患者与未服用过的精神分裂症患者进行了比较。两组在症状发作年龄或首次入院年龄方面均无显著差异。